XML 53 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Schedule of calculation of earnings per share
arnings per share attributable to Valeant Pharmaceuticals International, Inc. for the three-month and nine-month periods ended September 30, 2015 and 2014 were calculated as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2015
 
2014
 
2015
 
2014
Net income attributable to Valeant Pharmaceuticals International, Inc.
$
49.5

 
$
275.4

 
$
70.2

 
$
378.6

 
 
 
 
 
 
 
 
Basic weighted-average number of common shares outstanding
344.9

 
335.4

 
340.8

 
335.2

Diluted effect of stock options, RSUs and other
6.1

 
5.9

 
6.4

 
6.2

Diluted weighted-average number of common shares outstanding
351.0

 
341.3

 
347.2

 
341.4

 
 
 
 
 
 
 
 
Earnings per share attributable to Valeant Pharmaceuticals International, Inc.:
 
 
 
 
 
 
 
Basic
$
0.14

 
$
0.82

 
$
0.21

 
$
1.13

Diluted
$
0.14

 
$
0.81

 
$
0.20

 
$
1.11